In a groundbreaking step for India’s biotechnology sector, Union Minister Dr. Jitendra Singh formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections.
The antibiotic "Naphithromycin" has been developed in collaboration with the "Biotechnology Industry Research Assistance Council" (BIRAC), a unit of the Department of Biotechnology and has been marketed under the name "Miknaf" by the pharma company "Volkhardt".
It is the country's first indigenously developed antibiotic that aims to tackle antimicrobial resistance (AMR).
